Chronic Myelomonocytic Leukemia (CMML) Latest Advances
Find the Latest Research About Chronic Myelomonocytic Leukemia (CMML)
Last Updated: 06/30/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 2075 publications
CD69 blockade restores the bone marrow niche and delays leukemogenesis in a mouse model of Nras G12D-driven chronic myelomonocytic leukemia.
Journal: Cancer biology & therapy
Published: June 22, 2026
Chronic Myelomonocytic Leukemia (CMML) with Novel t(1;3)(p36.2;p12): Dual-locus Genomic Disruption Associated with Early Mortality.
Journal: Journal of the Association of Genetic Technologists
Published: June 05, 2026
Clinical Characteristics and Prognostic Analysis of the Chronic Myelomonocytic Leukemia
Journal: Zhongguo shi yan xue ye xue za zhi
Published: June 02, 2026
The scaffold protein PRR14L is linked to mitotic fidelity and sensitivity to MPS1 inhibition.
Journal: Molecular biology of the cell
Published: May 20, 2026
From Molecular Complexity to Personalized Care in Chronic Myelomonocytic Leukemia.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: May 07, 2026
Splicing factor mutations clearance and outcomes in clonal myeloid neoplasms: a referral center experience.
Journal: Annals of hematology
Published: April 25, 2026
Treatment of systemic mastocytosis with associated hematologic neoplasm: midostaurin and beyond.
Journal: Expert review of hematology
Published: April 07, 2026
A phase I open label study of fostamatinib, a SYK inhibitor, in patients with lower-risk myelodysplastic syndrome and chronic myelomonocytic leukemia.
Journal: Leukemia & lymphoma
Published: March 30, 2026
Molecular-Based Ecosystem to Improve Personalized Medicine in Chronic Myelomonocytic Leukemia.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: March 27, 2026
Final analysis of phase 2 clinical trial of ruxolitinib and azacitidine combination therapy in patients with myelodysplastic syndrome/myeloproliferative neoplasms.
Journal: Journal of hematology & oncology
Published: March 25, 2026
Last Updated: 06/30/2026